Drug Abuse Testing Market By Product & Services, Sample Type and End User - Global Industry Analysis & Forecast to 2027
Published On : April 2019 Pages : 170 Category: Medical Devices Report Code : HC043092
Drug Abuse Testing Market By Product & Services (Consumables, Laboratory Services, Analyzers, Rapid Testing Devices) Sample Type (Oral Fluid, Breath, Urine, Hair, Others) End User (Criminal Justice Systems and Law Enforcement Agencies, Workplaces & Schools, Hospitals, Research Laboratories) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Drug Abuse Testing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Business protocols of drug abuse testing have experienced extensive change over the ongoing years, to remain side by side of the steady ascent in the new substances that are being manhandled, elective grids, and market requests. Drug abuse test is a non-invasive specialized examination of organic examples, for example, hair, urine, blood, and others, to analyze the nearness of unlawful, doctor prescribed medications, or their metabolites. Among this pee testing is the most favored example type utilized for drugs of abuse testing.
Drivers and Restraints
The ascend in number of individuals who devour liquor and illegal drugs , for example, cocaine, marijuana, and others, is one of the significant drivers for the medication misuse testing market. Also, advancements in technology in devices used for drug testing and stringent government guidelines commanding medication screening support the market development. Nonetheless, lacking awareness and thought of medication testing as a rupture of protection rights in specific nations confine the development of the drug abuse testing market.
Regional Insights
North America ruled the market in 2022, representing the most noteworthy share, and is foreseen to keep up this pattern all through the figure time frame. This is credited to the ascent in usage of drugs of abuse in this region.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Alfa Scientific Designs
- MPD, Inc
- Shimadzu
- SureHire
- Omega Laboratories
- OraSure
- Lifeloc
- Premier Biotech
- Psychemedics
- CannAmm
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Drug Abuse Testing Market, By Product and Services, Estimates and Forecast, 2017-2027 ($Million)
o Laboratory Services
o Analyzers
o Consumables
o Rapid Testing Devices
· Drug Abuse Testing Market, By Sample Type, Estimates and Forecast, 2017-2027 ($Million)
o Oral Fluid (Saliva)
o Urine
o Hair
o Breath
o Others
· Drug Abuse Testing Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Research Laboratories
o Workplaces & Schools
o Criminal Justice Systems and Law Enforcement Agencies
o Hospitals
· Drug Abuse Testing Market, By Key Players
o Hoffmann-La Roche AG
o Abbott Laboratories
o Drägerwerk AG & Co. KGAA
o Express Diagnostics International Inc
o Siemens AG
o Biorad Laboratories, Inc
o Thermo Fisher Scientific, Inc.
o Danaher Corporation
o OraSure
o Quest Diagnostics Incorporated
o Alfa Scientific Designs
· Drug Abuse Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Drug Abuse Testing Market, By Country
o U.S. Drug Abuse Testing Market
o Canada Drug Abuse Testing Market
o Mexico Drug Abuse Testing Market
o Europe
§ Europe Drug Abuse Testing Market, By Country
o Germany Drug Abuse Testing Market
o UK Drug Abuse Testing Market
o France Drug Abuse Testing Market
o Russia Drug Abuse Testing Market
o Italy Drug Abuse Testing Market
o Rest of Europe Drug Abuse Testing Market
o Asia-Pacific
§ Asia-Pacific Drug Abuse Testing Market, By Country
o China Drug Abuse Testing Market
o Japan Drug Abuse Testing Market
o South Korea Drug Abuse Testing Market
o India Drug Abuse Testing Market
o Southeast Asia Drug Abuse Testing Market
o Rest of Asia-Pacific Drug Abuse Testing Market
o South America
§ South America Drug Abuse Testing Market
o Brazil Drug Abuse Testing Market
o Argentina Drug Abuse Testing Market
o Columbia Drug Abuse Testing Market
o Rest of South America Drug Abuse Testing Market
o Middle East and Africa
§ Middle East and Africa Drug Abuse Testing Market
o Saudi Arabia Drug Abuse Testing Market
o UAE Drug Abuse Testing Market
o Egypt Drug Abuse Testing Market
o Nigeria Drug Abuse Testing Market
o South Africa Drug Abuse Testing Market
o Rest of MEA Drug Abuse Testing Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Drug Abuse Testing Market, By Product And Services
5.1. Introduction
5.2. Global Drug Abuse Testing Revenue and Market Share by Product And Services (2017-2027)
5.2.1. Global Drug Abuse Testing Revenue and Revenue Share by Product And Services (2017-2027)
5.3. Laboratory Services
5.3.1. Global Laboratory Services Revenue and Growth Rate (2017-2027)
5.4. Analyzers
5.4.1. Global Analyzers Revenue and Growth Rate (2017-2027)
5.5. Consumables
5.5.1. Global Consumables Revenue and Growth Rate (2017-2027)
5.6. Rapid Testing Devices
5.6.1. Global Rapid Testing Devices Revenue and Growth Rate (2017-2027)
6. Drug Abuse Testing Market, By Sample Type
6.1. Introduction
6.2. Global Drug Abuse Testing Revenue and Market Share by Sample Type (2017-2027)
6.2.1. Global Drug Abuse Testing Revenue and Revenue Share by Sample Type (2017-2027)
6.3. Oral Fluid (Saliva)
6.3.1. Global Oral Fluid (Saliva) Revenue and Growth Rate (2017-2027)
6.4. Urine
6.4.1. Global Urine Revenue and Growth Rate (2017-2027)
6.5. Hair
6.5.1. Global Hair Revenue and Growth Rate (2017-2027)
6.6. Breath
6.6.1. Global Breath Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Drug Abuse Testing Market, By End User
7.1. Introduction
7.2. Global Drug Abuse Testing Revenue and Market Share by End User (2017-2027)
7.2.1. Global Drug Abuse Testing Revenue and Revenue Share by End User (2017-2027)
7.3. Research Laboratories
7.3.1. Global Research Laboratories Revenue and Growth Rate (2017-2027)
7.4. Workplaces & Schools
7.4.1. Global Workplaces & Schools Revenue and Growth Rate (2017-2027)
7.5. Criminal Justice Systems and Law Enforcement Agencies
7.5.1. Global Criminal Justice Systems and Law Enforcement Agencies Revenue and Growth Rate (2017-2027)
7.6. Hospitals
7.6.1. Global Hospitals Revenue and Growth Rate (2017-2027)
8. Drug Abuse Testing Market, By Region
8.1. Introduction
8.2. Global Drug Abuse Testing Revenue and Market Share by Regions
8.2.1. Global Drug Abuse Testing Revenue by Regions (2017-2027)
8.3. North America Drug Abuse Testing by Countries
8.3.1. North America Drug Abuse Testing Revenue and Growth Rate (2017-2027)
8.3.2. North America Drug Abuse Testing Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Drug Abuse Testing by Countries
8.4.1. Europe Drug Abuse Testing Revenue and Growth Rate (2017-2027)
8.4.2. Europe Drug Abuse Testing Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Drug Abuse Testing by Countries
8.5.1. Asia-Pacific Drug Abuse Testing Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Drug Abuse Testing Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Drug Abuse Testing by Countries
8.6.1. South America Drug Abuse Testing Revenue and Growth Rate (2017-2027)
8.6.2. South America Drug Abuse Testing Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Drug Abuse Testing by Countries
8.7.1. Middle East and Africa Drug Abuse Testing Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Drug Abuse Testing Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Hoffmann-La Roche AG
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Abbott Laboratories
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Drägerwerk AG & Co. KGAA
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Express Diagnostics International Inc
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Siemens AG
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Biorad Laboratories, Inc
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Thermo Fisher Scientific, Inc.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Danaher Corporation
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. OraSure
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Quest Diagnostics Incorporated
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
9.11. Alfa Scientific Designs
9.11.1. Business Overview
9.11.2. Service Portfolio
9.11.3. Strategic Developments
9.11.4. Financial Overview
10. Global Drug Abuse Testing Market Competition, by Manufacturer
10.1. Global Drug Abuse Testing Financial Overview by Manufacturer (2017-2017)
10.2. Global Drug Abuse Testing Price By Region (2017-2017)
10.3. Top 5 Drug Abuse Testing Manufacturer Market Share
10.4. Market Competition Trend
11. Drug Abuse Testing Market Forecast (2017-2027)
11.1. Global Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Drug Abuse Testing Market Forecast by Regions (2017-2027)
11.2.1. North America Drug Abuse Testing Market Forecast (2017-2027)
11.2.1.1. United States Drug Abuse Testing Market Forecast (2017-2027)
11.2.1.2. Canada Drug Abuse Testing Market Forecast (2017-2027)
11.2.1.3. Mexico Drug Abuse Testing Market Forecast (2017-2027)
11.2.2. Europe Drug Abuse Testing Market Forecast (2017-2027)
11.2.2.1. Germany Drug Abuse Testing Market Forecast (2017-2027)
11.2.2.2. France Drug Abuse Testing Market Forecast (2017-2027)
11.2.2.3. UK Drug Abuse Testing Market Forecast (2017-2027)
11.2.2.4. Russia Drug Abuse Testing Market Forecast (2017-2027)
11.2.2.5. Italy Drug Abuse Testing Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Drug Abuse Testing Market Forecast (2017-2027)
11.2.3. Asia-Pacific Drug Abuse Testing Market Forecast (2017-2027)
11.2.3.1. China Drug Abuse Testing Market Forecast (2017-2027)
11.2.3.2. Japan Drug Abuse Testing Market Forecast (2017-2027)
11.2.3.3. Korea Drug Abuse Testing Market Forecast (2017-2027)
11.2.3.4. India Drug Abuse Testing Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Drug Abuse Testing Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Drug Abuse Testing Market Forecast (2017-2027)
11.2.4. South America Drug Abuse Testing Market Forecast (2017-2027)
11.2.4.1. Brazil Drug Abuse Testing Market Forecast (2017-2027)
11.2.4.2. Argentina Drug Abuse Testing Market Forecast (2017-2027)
11.2.4.3. Columbia Drug Abuse Testing Market Forecast (2017-2027)
11.2.4.4. Rest of South America Drug Abuse Testing Market Forecast (2017-2027)
11.2.5. Middle East and Africa Drug Abuse Testing Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Drug Abuse Testing Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Drug Abuse Testing Market Forecast (2017-2027)
11.2.5.3. Egypt Drug Abuse Testing Market Forecast (2017-2027)
11.2.5.4. Nigeria Drug Abuse Testing Market Forecast (2017-2027)
11.2.5.5. South Africa Drug Abuse Testing Market Forecast (2017-2027)
11.2.5.6. Turkey Drug Abuse Testing Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Drug Abuse Testing Market Forecast (2017-2027)
11.3. Drug Abuse Testing Market Forecast by Product And Services (2017-2027)
11.3.1. Drug Abuse Testing Forecast by Product And Services (2017-2027)
11.3.2. Drug Abuse Testing Market Share Forecast by Product And Services (2017-2027)
11.4. Drug Abuse Testing Market Forecast by Sample Type (2017-2027)
11.4.1. Drug Abuse Testing Forecast by Sample Type (2017-2027)
11.4.2. Drug Abuse Testing Market Share Forecast by Sample Type (2017-2027)
11.5. Drug Abuse Testing Market Forecast by End User (2017-2027)
11.5.1. Drug Abuse Testing Forecast by End User (2017-2027)
11.5.2. Drug Abuse Testing Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Drug Abuse Testing Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Drug Abuse Testing Revenue and Revenue Share by Product And Services (2017-2018)
Figure Global Laboratory Services Revenue and Growth Rate (2017-2018)
Figure Global Analyzers Revenue and Growth Rate (2017-2018)
Figure Global Consumables Revenue and Growth Rate (2017-2018)
Figure Global Rapid Testing Devices Revenue and Growth Rate (2017-2018)
Table Global Drug Abuse Testing Revenue and Revenue Share by Sample Type (2017-2018)
Figure Global Oral Fluid (Saliva) Revenue and Growth Rate (2017-2018)
Figure Global Urine Revenue and Growth Rate (2017-2018)
Figure Global Hair Revenue and Growth Rate (2017-2018)
Figure Global Breath Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Drug Abuse Testing Revenue and Revenue Share by End User (2017-2018)
Figure Global Research Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Workplaces & Schools Revenue and Growth Rate (2017-2018)
Figure Global Criminal Justice Systems and Law Enforcement Agencies Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global Drug Abuse Testing Revenue by Regions (2017-2018)
Figure North America Drug Abuse Testing Growth Rate (2017-2018)
Figure North America Drug Abuse Testing Revenue and Growth Rate (2017-2018)
Figure North America Drug Abuse Testing by Countries (2017-2018)
Figure North America Drug Abuse Testing Revenue (Million USD) by Countries (2017-2018)
Figure United States Drug Abuse Testing Growth Rate (2017-2018)
Figure United States Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Drug Abuse Testing Growth Rate (2017-2018)
Figure Canada Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Drug Abuse Testing Growth Rate (2017-2018)
Figure Mexico Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Drug Abuse Testing Growth Rate (2017-2018)
Figure Europe Drug Abuse Testing Revenue and Growth Rate (2017-2018)
Figure Europe Drug Abuse Testing by Countries (2017-2018)
Figure Europe Drug Abuse Testing Revenue (Million USD) by Countries (2017-2018)
Figure Germany Drug Abuse Testing Growth Rate (2017-2018)
Figure Germany Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Drug Abuse Testing Growth Rate (2017-2018)
Figure France Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Drug Abuse Testing Growth Rate (2017-2018)
Figure UK Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Drug Abuse Testing Growth Rate (2017-2018)
Figure Russia Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Drug Abuse Testing Growth Rate (2017-2018)
Figure Italy Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Drug Abuse Testing Growth Rate (2017-2018)
Figure Rest of Europe Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Drug Abuse Testing Growth Rate (2017-2018)
Figure Asia-Pacific Drug Abuse Testing Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Drug Abuse Testing by Countries (2017-2018)
Figure Asia-Pacific Drug Abuse Testing Revenue (Million USD) by Countries (2017-2018)
Figure China Drug Abuse Testing Growth Rate (2017-2018)
Figure China Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Drug Abuse Testing Growth Rate (2017-2018)
Figure Japan Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Drug Abuse Testing Growth Rate (2017-2018)
Figure Korea Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Drug Abuse Testing Growth Rate (2017-2018)
Figure India Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Drug Abuse Testing Growth Rate (2017-2018)
Figure Southeast Asia Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Drug Abuse Testing Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Drug Abuse Testing Growth Rate (2017-2018)
Figure South America Drug Abuse Testing Revenue and Growth Rate (2017-2018)
Figure South America Drug Abuse Testing by Countries (2017-2018)
Figure South America Drug Abuse Testing Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Drug Abuse Testing Growth Rate (2017-2018)
Figure Brazil Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Drug Abuse Testing Growth Rate (2017-2018)
Figure Argentina Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Drug Abuse Testing Growth Rate (2017-2018)
Figure Columbia Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Drug Abuse Testing Growth Rate (2017-2018)
Figure Rest of South America Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Drug Abuse Testing Growth Rate (2017-2018)
Figure Middle East and Africa Drug Abuse Testing Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Drug Abuse Testing by Countries (2017-2018)
Figure Middle East and Africa Drug Abuse Testing Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Drug Abuse Testing Growth Rate (2017-2018)
Figure Saudi Arabia Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Drug Abuse Testing Growth Rate (2017-2018)
Figure United Arab Emirates Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Drug Abuse Testing Growth Rate (2017-2018)
Figure Egypt Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Drug Abuse Testing Growth Rate (2017-2018)
Figure Nigeria Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Drug Abuse Testing Growth Rate (2017-2018)
Figure South Africa Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Drug Abuse Testing Growth Rate (2017-2018)
Figure Turkey Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Drug Abuse Testing Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Table Hoffmann-La Roche AG Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Drägerwerk AG & Co. KGAA Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Express Diagnostics International Inc Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Siemens AG Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Biorad Laboratories, Inc Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific, Inc. Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Danaher Corporation Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table OraSure Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Quest Diagnostics Incorporated Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Alfa Scientific Designs Drug Abuse Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Drug Abuse Testing Market Share by Manufacturer
Figure Global Drug Abuse Testing Revenue and Market Share by Manufacturer
Table Global Drug Abuse Testing Price by Region (2017-2017)
Figure Top 5 Drug Abuse Testing Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Drug Abuse Testing Revenue (Millions USD) and Growth Rate (2018-2025)
Table Drug Abuse Testing Market Forecast by Regions (2018-2025)
Figure North America Drug Abuse Testing Market Forecast (2018-2025)
Figure United States Drug Abuse Testing Market Forecast (2018-2025)
Figure Canada Drug Abuse Testing Market Forecast (2018-2025)
Figure Mexico Drug Abuse Testing Market Forecast (2018-2025)
Figure Europe Drug Abuse Testing Market Forecast (2018-2025)
Figure Germany Drug Abuse Testing Market Forecast (2018-2025)
Figure France Drug Abuse Testing Market Forecast (2018-2025)
Figure UK Drug Abuse Testing Market Forecast (2018-2025)
Figure Russia Drug Abuse Testing Market Forecast (2018-2025)
Figure Italy Drug Abuse Testing Market Forecast (2018-2025)
Figure Rest of Europe Drug Abuse Testing Market Forecast (2018-2025)
Figure Asia-Pacific Drug Abuse Testing Market Forecast (2018-2025)
Figure China Drug Abuse Testing Market Forecast (2018-2025)
Figure Japan Drug Abuse Testing Market Forecast (2018-2025)
Figure Korea Drug Abuse Testing Market Forecast (2018-2025)
Figure India Drug Abuse Testing Market Forecast (2018-2025)
Figure Southeast Asia Drug Abuse Testing Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Drug Abuse Testing Market Forecast (2018-2025)
Figure South America Drug Abuse Testing Market Forecast (2018-2025)
Figure Brazil Drug Abuse Testing Market Forecast (2018-2025)
Figure Argentina Drug Abuse Testing Market Forecast (2018-2025)
Figure Columbia Drug Abuse Testing Market Forecast (2018-2025)
Figure Rest of South America Drug Abuse Testing Market Forecast (2018-2025)
Figure Middle East and Africa Drug Abuse Testing Market Forecast (2018-2025)
Figure Saudi Arabia Drug Abuse Testing Market Forecast (2018-2025)
Figure United Arab Emirates Drug Abuse Testing Market Forecast (2018-2025)
Figure Egypt Drug Abuse Testing Market Forecast (2018-2025)
Figure Nigeria Drug Abuse Testing Market Forecast (2018-2025)
Figure South Africa Drug Abuse Testing Market Forecast (2018-2025)
Figure Turkey Drug Abuse Testing Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Drug Abuse Testing Market Forecast (2018-2025)
Figure Global Drug Abuse Testing Forecast by Product And Services (2018-2025)
Figure Global Drug Abuse Testing Market Share Forecast by Product And Services (2018-2025)
Figure Global Drug Abuse Testing Forecast by Product And Services (2018-2025)
Figure Global Drug Abuse Testing Forecast by Sample Type (2018-2025)
Figure Global Drug Abuse Testing Market Share Forecast by Sample Type (2018-2025)
Figure Global Drug Abuse Testing Forecast by Sample Type (2018-2025)
Figure Global Drug Abuse Testing Forecast by End User (2018-2025)
Figure Global Drug Abuse Testing Market Share Forecast by End User (2018-2025)
Figure Global Drug Abuse Testing Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|